GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance

U.S. Markets closed

Gilead Sciences Inc. (GILD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
70.69-0.32 (-0.45%)
At close: 4:00PM EST

70.69 0.00 (0.00%)
After hours: 4:00PM EST

People also watch
CELGBIIBAMGNREGNBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close71.01
Open70.87
Bid70.76 x 700
Ask70.77 x 900
Day's Range70.30 - 71.29
52 Week Range70.30 - 103.10
Volume9,202,887
Avg. Volume9,787,206
Market Cap93.13B
Beta0.88
PE Ratio (TTM)6.54
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.88 (2.65%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Gilead Clobbered On Hep C; 'Little Value' In 'Too Late' NASH, HIV Units
    Investor's Business Daily2 hours ago

    Gilead Clobbered On Hep C; 'Little Value' In 'Too Late' NASH, HIV Units

    Gilead, Amgen and AbbVie underperformed in Q4, Leerink analyst Geoffrey Porges predicted Monday.

  • Barrons.com6 hours ago

    Gilead Sciences: The Foggy Crystal Ball

    Gilead Sciences (GILD) reports earnings on Feb. 7--which means that analysts everywhere are trying to predict what its numbers and guidance might look like. Last week, RBC's Michael Yee and team noted that "visibility is tough on Hepatitis C right now," and today Credit Suisse analyst Alethia Young and team note their agreement: Gilead- we think it will be difficult for the company to guide the HCV business as patient starts remain difficult to forecast. Numbers have come in for Gilead which helps for the set up into the guidance announcement.

  • Has Gilead Sciences' Cash Cow Finally Hit Bottom?
    Motley Fool6 hours ago

    Has Gilead Sciences' Cash Cow Finally Hit Bottom?

    And what does that mean for the stock long-term?